BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6751010)

  • 21. [Aldosterone excretion and plasma renin activity in patients with essential hypertension and with primary aldosteronism (author's transl)].
    Helber A; Meurer KA; Rosskamp E; Wambach G; Dickmans HA; Kaufmann W
    Klin Wochenschr; 1974 Oct; 52(20):966-73. PubMed ID: 4444216
    [No Abstract]   [Full Text] [Related]  

  • 22. Normal renin-aldosterone-insulin and potassium interrelationship in FMF patients and amyloid nephropathy.
    Shemer J; Royburt M; Cabili S; Iaina A; Pras M; Eliahou H
    Ren Fail; 1992; 14(4):555-62. PubMed ID: 1462007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum aldosterone changes during hyperinsulinemia are correlated to body mass index and insulin sensitivity in patients with essential hypertension.
    Haenni A; Reneland R; Lind L; Lithell H
    J Hypertens; 2001 Jan; 19(1):107-12. PubMed ID: 11204289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of aldosterone secretion in primary aldosteronism.
    Vetter H; Vetter W
    Horm Metab Res; 1975 Sep; 7(5):418-24. PubMed ID: 1183923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary tetrahydroaldosterone as a screening method for primary aldosteronism: a comparative study.
    Abdelhamid S; Blomer R; Hommel G; Haack D; Lewicka S; Fiegel P; Krumme B
    Am J Hypertens; 2003 Jul; 16(7):522-30. PubMed ID: 12850384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Rectal electrical potential difference and plasma aldosterone in hyperaldosteronism and low-, normal- and high-renin hypertension].
    Skrabal F; Mauser R
    Wien Klin Wochenschr; 1976 Dec; 88(23):777-81. PubMed ID: 1014711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aldosterone and other mineralocorticoids in Bartter's syndrome.
    Saruta T; Fujimaki M; Senba S; Saito I; Konishi K
    J Lab Clin Med; 1984 Jun; 103(6):848-53. PubMed ID: 6373989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of captopril on aldosterone response to potassium infusion in primary aldosteronism.
    Fallo F; Chouman M; Pagotto U; Pistorello M
    Miner Electrolyte Metab; 1991; 17(3):185-9. PubMed ID: 1779941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circadian rhythm and effect of posture on plasma aldosterone concentration in primary aldosteronism.
    Schambelan M; Brust NL; Chang BC; Slater KL; Biglieri EG
    J Clin Endocrinol Metab; 1976 Jul; 43(1):115-31. PubMed ID: 947931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potassim-aldosterone-renin interrelationships.
    Himathongkam T; Dluhy RG; Williams GH
    J Clin Endocrinol Metab; 1975 Jul; 41(1):153-9. PubMed ID: 1167307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of surgical treatment on secondary hyperaldosteronism and relative hyperinsulinemia in primary hyperparathyroidism.
    Kovács L; Góth MI; Szabolcs I; Dohán O; Ferencz A; Szilágyi G
    Eur J Endocrinol; 1998 May; 138(5):543-7. PubMed ID: 9625366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the pathogenesis of Bartter's syndrome: report of studies in a patient with this disorder.
    Norby L; Mark AL; Kaloyanides GJ
    Clin Nephrol; 1976 Sep; 6(3):404-13. PubMed ID: 991467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Excretion of aldosterone in the urine, renin activity in the plasma and some indices of the metabolism of potassium and sodium in patients with the iodiopathic edema syndrome].
    Egart FM; Atamanova TM; Egorova IA; Korotkova VD; Golokhvostova IF
    Probl Endokrinol (Mosk); 1975; 21(3):45-9. PubMed ID: 1144321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of a spirolactone on plasma and urinary aldosterone in primary aldosteronism.
    Vetter H; Appenheimer M; Lucas R; Weiand H; Herschbach ML; Glänzer K; Witassek F; Krück F
    Horm Res; 1977; 8(1):23-8. PubMed ID: 892704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical, biochemical and genetic approaches to the detection of familial hyperaldosteronism type I.
    Stowasser M; Bachmann AW; Jonsson JR; Tunny TJ; Klemm SA; Gordon RD
    J Hypertens; 1995 Dec; 13(12 Pt 2):1610-3. PubMed ID: 8903619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A low molecular weight heparin decreases plasma aldosterone in patients with primary hyperaldosteronism.
    Cailleux N; Moore N; Levesque H; Courtois H; Godin M
    Eur J Clin Pharmacol; 1992; 43(2):185-7. PubMed ID: 1330575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of ACTH in the episodic release of aldosterone in patients with idiopathic adrenal hyperplasia, hypertension, and hyperaldosteronism.
    Kem DC; Weinberger MH; Gomez-Sanchez C; Higgins JR; Kramer NJ
    J Lab Clin Med; 1976 Aug; 88(2):261-70. PubMed ID: 182890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of primary hyperaldosteronism in a systemic arterial hypertension league.
    Ribeiro MJ; Figueiredo Neto JA; Memória EV; Lopes Mde C; Faria Mdos S; Salgado Filho N; Oliveira TC
    Arq Bras Cardiol; 2009 Jan; 92(1):39-45. PubMed ID: 19219263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Conn's adenoma. Diagnostic and prognostic value of the measurement of potassium, renin, aldosterone levels and the aldosterone/renin ratio].
    Massien-Simon C; Battaglia C; Chatellier G; Guyene TT; Duclos JM; Plouin PF
    Presse Med; 1995 Sep; 24(27):1238-42. PubMed ID: 7501604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.